Parallax Volatility Advisers, L.P. Aerie Pharmaceuticals Inc Call Options Transaction History

Parallax Volatility Advisers, L.P.

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q1 2019 May 15, 2019	SELL	$36.32 - $49.25 $635,600 - $861,875	-17,500 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$33.0 - $60.04 $577,500 - $1.05 Million	17,500 New	17,500 $632,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.